We employed super-resolution imaging to show that CH60–TLR4 complexes preexist on MM cells and genetic, pharmacological, and biochemical analyses provide evidence that CH60 acts via TLR4 to induce NF-κB signaling, up-regulation of anti-apoptotic genes, and drug resistance in MM cells. The gene discussed is TLR4; the disease is Miyoshi myopathy.